The Global Vaccine Vials Market to grow from USD 421.57 Million in 2019 to USD 745.22 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 9.96%.
Market Segmentation & Coverage:
The research report categorizes the Vaccine Vials Market to forecast the revenues and analyze the trends in each of the following segments:
Based on Type, the Vaccine Vials Market studied across Multi Dose and Single Dose.
Based on Material, the Vaccine Vials Market studied across Glass and Polymer.
Based on Capacity, the Vaccine Vials Market studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
Based on Application, the Vaccine Vials Market studied across Preventive Vaccine and Therapeutic Vaccine.
"The Asia-Pacific is projected to witness the highest growth during the forecast period"
Based on Geography, the Vaccine Vials Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Vaccine Vials Market in 2019, followed by the Americas. On the other hand, the Asia-Pacific expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.
The factors attributing to the growth of the market are growing initiatives from government and private organizations to advance vaccination, increasing demand for a large number of vaccines for the sales of vaccine vials, and high prevalence of infectious diseases and rise of pharmaceutical industries. However, some factors such as lack of healthcare infrastructure in developing countries such as brazil, india, and china may hinder the market growth. The Vaccine Vials Market expected to showcase the opportunities such as rising awareness of immunization among the people regarding the endemic diseases, attractive investment in vaccine vial monitor (vvm), and development of innovative vaccine administration methods. Soon market may face the possible challenges in the growth due to high-cost associated with the supply chain of vaccine vials. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Company Usability Profiles:
The Vaccine Vials Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Vials Market, including Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., SiO2 Medical Products, Stevanato Group, Thermo Fisher Scientific Inc, and Vetter Pharma-Fertigung GmbH & Co. KG..